Abstract

BackgroundThere is a vast need to find clinically applicable protein biomarkers as support in cancer diagnosis and tumour classification. In proteomics research, a number of methods can be used to obtain systemic information on protein and pathway level on cells and tissues. One fundamental tool in analysing protein expression has been two-dimensional gel electrophoresis (2DE). Several cancer 2DE studies have reported partially redundant lists of differently expressed proteins. To be able to further extract valuable information from existing 2DE data, the power of a multivariate meta-analysis will be evaluated in this work.ResultsWe here demonstrate a multivariate meta-analysis of 2DE proteomics data from human prostate and colon tumours. We developed a bioinformatic workflow for identifying common patterns over two tumour types. This included dealing with pre-processing of data and handling of missing values followed by the development of a multivariate Partial Least Squares (PLS) model for prediction and variable selection. The variable selection was based on the variables performance in the PLS model in combination with stability in the validation. The PLS model development and variable selection was rigorously evaluated using a double cross-validation scheme. The most stable variables from a bootstrap validation gave a mean prediction success of 93% when predicting left out test sets on models discriminating between normal and tumour tissue, common for the two tumour types. The analysis conducted in this study identified 14 proteins with a common trend between the tumour types prostate and colon, i.e. the same expression profile between normal and tumour samples.ConclusionsThe workflow for meta-analysis developed in this study enabled the finding of a common protein profile for two malign tumour types, which was not possible to identify when analysing the data sets separately.

Highlights

  • There is a vast need to find clinically applicable protein biomarkers as support in cancer diagnosis and tumour classification

  • The filtering of spots was based on fraction of present values over both prostate and colon samples

  • When excluding spots missing in one data set the largest variation is shifted towards the spread within the data sets. This filtering decreases the “batch effect” seen in the Principal Component Analysis [20] (PCA) scores plot (Figure 3) caused by integrating the two disparate data sets generated by two different prior studies

Read more

Summary

Introduction

There is a vast need to find clinically applicable protein biomarkers as support in cancer diagnosis and tumour classification. Proteome analysis can provide valuable phenotypic information of tumour tissue on the molecular level. To be able to further extract valuable information from existing 2DE data, meta-analysis in combination with multivariate methods will be explored in this work. A meta-analysis combines the data from several studies and can for example be used to study more general protein patterns over several different tumour types. I.e. general molecular changes related to tumour progression such as proteins and protein patterns manifesting highly metastatic tumours, and biomarkers specific for a certain tumour type as well as those biomarkers that reveal tissue of origin of metastatic disease. A meta-analysis allows distinguishing the common proteins playing a crucial role in oncogenic processes from those that are differently expressed only in certain tumour types

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.